Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

ALL Assembly 2018

5 - 6 Oct 2018
Park Inn by Radisson Amsterdam City West HotelPark Inn by Radisson Amsterdam City West Hotel, Amsterdam, Netherlands
Videos

Immunological monitoring of patients receiving immunotherapy

Prof Jaques van Dongen - Leiden University, Netherlands
Immunological monitoring of patients receiving immunotherapy ( Prof Jaques van Dongen - Leiden University, Netherlands )
18 Oct 2018

Novel therapies for paediatric B-ALL

Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy
Novel therapies for paediatric B-ALL ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )
18 Oct 2018

Can we reduce the intensity of frontline therapy?

Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy
Can we reduce the intensity of frontline therapy? ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )
18 Oct 2018

Latest concepts in the diagnosis of genetic ALL subtypes

Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA
Latest concepts in the diagnosis of genetic ALL subtypes ( Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA )
18 Oct 2018

In vitro diagnostic models for ALL: what can we learn on actionable targets?

Dr Beat Bornhauser - Senior Scientist, University of Zurich, Zurich, Switzerland
In vitro diagnostic models for ALL: what can we learn on actionable targets? ( Dr Beat Bornhauser - Senior Scientist, University of Zurich, Zurich, Switzerland )
18 Oct 2018

For HSCT in Ph-positive ALL

Prof Oliver Ottmann - Cardiff University, Cardiff, UK
For HSCT in Ph-positive ALL ( Prof Oliver Ottmann - Cardiff University, Cardiff, UK )
18 Oct 2018

Bispecific T-cell engaging therapy for adult ALL

Prof Max Topp - University of Würzburg, Würzburg, Germany
Bispecific T-cell engaging therapy for adult ALL ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
18 Oct 2018

Optimal use of TKIs for therapy of Ph-positive ALL

Dr Josep Ribera - Catalan Institute of Oncology, Badalona, Spain
Optimal use of TKIs for therapy of Ph-positive ALL ( Dr Josep Ribera - Catalan Institute of Oncology, Badalona, Spain )
18 Oct 2018

Management of relapsed T-ALL in children

Prof Josef Vormoor - Newcastle University, Newcastle, UK
Management of relapsed T-ALL in children ( Prof Josef Vormoor - Newcastle University, Newcastle, UK )
18 Oct 2018

Combining MRD quantitation and genetics in post-remission risk stratification

Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK
Combining MRD quantitation and genetics in post-remission risk stratification ( Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK )
18 Oct 2018

Transplanting adult ALL patients

Prof Sebastien Giebel - The Maria Skłodowska-Curie Institute of Oncology, Warsaw, Poland
Transplanting adult ALL patients ( Prof Sebastien Giebel - The Maria Skłodowska-Curie Institute of Oncology, Warsaw, Poland )
18 Oct 2018

Management of MLL-rearranged ALL

Prof Rob Pieters - Princess Maxima Centre for paediatric oncology (UU), Utrecht, Netherlands
Management of MLL-rearranged ALL ( Prof Rob Pieters - Princess Maxima Centre for paediatric oncology (UU), Utrecht, Netherlands )
18 Oct 2018

Against HSCT in Ph-positive ALL

Prof Robin Foa - Professor of Haematology and Head of Haematology, University of Rome, Rome, Italy
Against HSCT in Ph-positive ALL ( Prof Robin Foa - Professor of Haematology and Head of Haematology, University of Rome, Rome, Italy )
18 Oct 2018

CAR-T cells: challenges and opportunities

Dr Sara Ghorashian - University College London, London, UK
CAR-T cells: challenges and opportunities ( Dr Sara Ghorashian - University College London, London, UK )
18 Oct 2018

Update on targeted therapies for Philadelphia-like ALL

Prof Stephen Hunger - Children’s Hospital of Philadelphia, Philadelphia, USA
Update on targeted therapies for Philadelphia-like ALL ( Prof Stephen Hunger - Children’s Hospital of Philadelphia, Philadelphia, USA )
18 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation